Literature DB >> 18330459

Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects.

Hymie Anisman1, Lisheng Du, Mikos Palkovits, Gabor Faludi, Gabor G Kovacs, Peter Szontagh-Kishazi, Zul Merali, Michael O Poulter.   

Abstract

OBJECTIVE: Studies comparing people suffering from depression who committed suicide with control subjects have yielded inconsistent results regarding serotonin (5-HT) involvement in pathology, possibly owing to procedural factors. Our objective was to investigate which 5-HT receptor subtypes might be associated with depression and suicide, whether receptor differences vary across brain regions and whether they are moderated by sex.
METHODS: We assessed messenger ribonucleic acid (mRNA) expression of several 5-HT receptor subtypes and that of p11, a protein involved in the functional expression of 5-HT(1B), in several stress-relevant brain regions. Tissue was obtained soon after death, and RNA integrity and pH was confirmed to be appropriate. Brain tissue from suicide subjects suffering from depression and from control subjects who had died from other causes (10 men and 10 women in each condition) was obtained within 6.5 hours postmortem. Quantitative polymerase chain reaction analyses determined mRNA expression of 5-HT receptor subtypes and p11 within the frontopolar cortex, orbitofrontal cortex, hippocampus, amygdala and paraventricular nucleus. The 5-HT transporter (5-HTT) was also assessed in the raphe nucleus.
RESULTS: Differences of 5-HT(1A), 5-HT(1B) and p11 mRNA expression between people who committed suicide and control subjects were relatively widespread, whereas 5-HT(2A) and 5-HT(2C) variations were restricted to the frontopolar cortex and amygdala. Within the dorsal raphe nucleus, neither 5-HT(1A) nor 5-HTT mRNA expression differed between those who committed suicide and control subjects.
CONCLUSION: Several 5-HT receptor subtypes are associated with depression and suicide, but these receptor differences vary across brain regions and are moderated by sex.

Entities:  

Keywords:  depression; receptors, serotonin; suicide

Mesh:

Substances:

Year:  2008        PMID: 18330459      PMCID: PMC2265306     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  71 in total

Review 1.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

Review 2.  Decision-making and the frontal lobes.

Authors:  Kirsten G Volz; Ricarda I Schubotz; D Yves von Cramon
Journal:  Curr Opin Neurol       Date:  2006-08       Impact factor: 5.710

3.  Identification of an AHNAK binding motif specific for the Annexin2/S100A10 tetramer.

Authors:  Sandrine De Seranno; Christelle Benaud; Nicole Assard; Sami Khediri; Volker Gerke; Jacques Baudier; Christian Delphin
Journal:  J Biol Chem       Date:  2006-09-19       Impact factor: 5.157

4.  Target brain sites of the anxiolytic effect of citalopram, a selective serotonin reuptake inhibitor.

Authors:  Takeshi Izumi; Takeshi Inoue; Yuji Kitaichi; Shin Nakagawa; Tsukasa Koyama
Journal:  Eur J Pharmacol       Date:  2006-02-21       Impact factor: 4.432

5.  alpha-[11C]Methyl-L-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters.

Authors:  Marco Leyton; Vincent Paquette; Paul Gravel; Pedro Rosa-Neto; Francine Weston; Mirko Diksic; Chawki Benkelfat
Journal:  Eur Neuropsychopharmacol       Date:  2005-11-02       Impact factor: 4.600

Review 6.  p11 (S100A10)--an inducible adaptor protein that modulates neuronal functions.

Authors:  Per Svenningsson; Paul Greengard
Journal:  Curr Opin Pharmacol       Date:  2006-11-07       Impact factor: 5.547

Review 7.  Genetics of emotional regulation: the role of the serotonin transporter in neural function.

Authors:  Ahmad R Hariri; Andrew Holmes
Journal:  Trends Cogn Sci       Date:  2006-03-10       Impact factor: 20.229

Review 8.  Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

Authors:  Mark J Millan
Journal:  Pharmacol Ther       Date:  2006-03-07       Impact factor: 12.310

9.  Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation.

Authors:  Per Svenningsson; Eleni T Tzavara; Hongshi Qi; Robert Carruthers; Jeffrey M Witkin; George G Nomikos; Paul Greengard
Journal:  J Neurosci       Date:  2007-04-11       Impact factor: 6.167

10.  Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.

Authors:  Zubin Bhagwagar; Rainer Hinz; Matthew Taylor; Sabrina Fancy; Philip Cowen; Paul Grasby
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

View more
  55 in total

Review 1.  The interpersonal theory of suicide.

Authors:  Kimberly A Van Orden; Tracy K Witte; Kelly C Cukrowicz; Scott R Braithwaite; Edward A Selby; Thomas E Joiner
Journal:  Psychol Rev       Date:  2010-04       Impact factor: 8.934

Review 2.  5-HT(1A) receptor function in major depressive disorder.

Authors:  Jonathan Savitz; Irwin Lucki; Wayne C Drevets
Journal:  Prog Neurobiol       Date:  2009-02-07       Impact factor: 11.685

3.  Human Freud-2/CC2D1B: a novel repressor of postsynaptic serotonin-1A receptor expression.

Authors:  Mahmoud R Hadjighassem; Mark C Austin; Bernadeta Szewczyk; Mireille Daigle; Craig A Stockmeier; Paul R Albert
Journal:  Biol Psychiatry       Date:  2009-05-07       Impact factor: 13.382

4.  Increased fear-potentiated startle in major depressive disorder patients with lifetime history of suicide attempt.

Authors:  Elizabeth D Ballard; Dawn F Ionescu; Jennifer L Vande Voort; Elizabeth E Slonena; Jose A Franco-Chaves; Carlos A Zarate; Christian Grillon
Journal:  J Affect Disord       Date:  2014-03-27       Impact factor: 4.839

Review 5.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

Review 6.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

Review 7.  Pathogenesis of depression: Insights from human and rodent studies.

Authors:  C Ménard; G E Hodes; S J Russo
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

8.  Hippocampal mossy cell involvement in behavioral and neurogenic responses to chronic antidepressant treatment.

Authors:  Seo-Jin Oh; Jia Cheng; Jin-Hyeok Jang; Jeffrey Arace; Minseok Jeong; Chang-Hoon Shin; Jeongrak Park; Junghee Jin; Paul Greengard; Yong-Seok Oh
Journal:  Mol Psychiatry       Date:  2019-03-05       Impact factor: 15.992

9.  A role for p11 in the antidepressant action of brain-derived neurotrophic factor.

Authors:  Jennifer L Warner-Schmidt; Emily Y Chen; Xiaoqun Zhang; John J Marshall; Alexei Morozov; Per Svenningsson; Paul Greengard
Journal:  Biol Psychiatry       Date:  2010-06-29       Impact factor: 13.382

10.  Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression.

Authors:  Gregory M Sullivan; R Todd Ogden; Maria A Oquendo; J S Dileep Kumar; Norman Simpson; Yung-yu Huang; J John Mann; Ramin V Parsey
Journal:  Biol Psychiatry       Date:  2009-03-17       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.